ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.

Pascale Romestaing , Brigitte Chapot , Norman Moullan , Paola Pisani
Cancer Research 63 ( 24) 8717 -8725

191
2003
No Association between GPX1 Pro198Leu and Breast Cancer Risk

Susan E. Hankinson , David G. Cox , Peter Kraft , David J. Hunter
Cancer Epidemiology, Biomarkers & Prevention 13 ( 11) 1821 -1822

50
2004
A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Commentary

Laurence N. Kolonel , Demetrius Albanes , Stephen J. Chanock , Christopher A. Haiman
Cancer Research 67 ( 7)

1
2007
The p53 R72P and MDM2 -309 polymorphisms and risk of breast cancer in the Nurses' Health Studies.

Shelley S. Tworoger , Dwayne Deer , Immaculata De Vivo , David G. Cox
Cancer Epidemiology and Prevention Biomarkers 15

2006
Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.

Aditi Hazra , Stephen Chanock , Edward Giovannucci , David G. Cox
Cancer Epidemiology, Biomarkers & Prevention 17 ( 2) 311 -319

16
2008
Vitamin D Receptor Polymorphisms and Breast Cancer Risk: Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium

James D. McKay , Marjorie L. McCullough , Regina G. Ziegler , Peter Kraft
Cancer Epidemiology, Biomarkers & Prevention 18 ( 1) 297 -305

72
2009
Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility

Mitchell J. Machiela , Thomas G. P. Grünewald , Didier Surdez , Stephanie Reynaud
Nature Communications 9 ( 1) 3184 -3184

20
2018
Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population

Jean-Nicolas Cornu , Geraldine Cancel-Tassin , David G. Cox , Morgan Roupret
European Urology 70 ( 1) 6 -8

3
2016
Data mining: Efficiency of using sequence databases for polymorphism discovery.

David G. Cox , Catherine Boillot , Federico Canzian
Human Mutation 17 ( 2) 141 -150

27
2001
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)

Laure Dossus , Rudolf Kaaks , Federico Canzian , Demetrius Albanes
Carcinogenesis 31 ( 3) 455 -461

60
2010
Polymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States).

David G. Cox , Susan E. Hankinson , David J. Hunter
Cancer Causes & Control 17 ( 1) 81 -83

78
2006
The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses' health studies.

David G. Cox , Dwayne Deer , Qun Guo , Shelley S. Tworoger
Cancer Causes & Control 18 ( 6) 621 -625

39
2007
Genetic Variability of the mTOR Pathway and Prostate Cancer Risk in the European Prospective Investigation on Cancer (EPIC)

Daniele Campa , Anika Hüsing , Angelika Stein , Lucie Dostal
PLoS ONE 6 ( 2) e16914 -7

79
2011
Study designs for genome-wide association studies.

Peter Kraft , David G. Cox
Advances in Genetics 60 465 -504

50
2008
Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk

David G. Cox , Walter C. Willett , Susan E. Hankinson , David J. Hunter
Breast Cancer Research and Treatment 115 ( 3) 613 -622

42
2009
Active and passive cigarette smoking and breast cancer risk: Results from the EPIC cohort

Laure Dossus , Marie‐Christine Boutron‐Ruault , Rudolf Kaaks , Inger T Gram
International Journal of Cancer 134 ( 8) 1871 -1888

89
2014
Genome-Wide Association Study of Circulating Estradiol, Testosterone, and Sex Hormone-Binding Globulin in Postmenopausal Women

Jennifer Prescott , Deborah J. Thompson , Peter Kraft , Stephen J. Chanock
PLOS ONE 7 ( 6)

48
2012
A Genome-Wide “Pleiotropy Scan” Does Not Identify New Susceptibility Loci for Estrogen Receptor Negative Breast Cancer

Daniele Campa , Myrto Barrdahl , Konstantinos K. Tsilidis , Gianluca Severi
PLoS ONE 9 ( 2) e85955

7
2014